• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Gα12 通过调节 NFATc1 的表达来调节破骨细胞的生成。

Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.

机构信息

Department of Cell and Developmental Biology, BK21 Program and Dental Research Institute, Seoul National University, Seoul, Korea.

College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul, Korea.

出版信息

J Cell Mol Med. 2018 Feb;22(2):849-860. doi: 10.1111/jcmm.13370. Epub 2017 Oct 27.

DOI:10.1111/jcmm.13370
PMID:29077264
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5783869/
Abstract

The G12 family of G protein alpha subunits has been shown to participate in the regulation of various physiological processes. However, the role of Gα12 in bone physiology has not been well described. Here, by micro-CT analysis, we discovered that Gα12-knockout mice have an osteopetrotic phenotype. Histological examination showed lower osteoclast number in femoral tissue of Gα12-knockout mice compared to wild-type mice. Additionally, in vitro osteoclastic differentiation of precursor cells with receptor activator of nuclear factor-κB ligand (RANKL) showed that Gα12 deficiency decreased the number of osteoclast generated and the bone resorption activity. The induction of nuclear factor of activated T-cell c1 (NFATc1), the key transcription factor of osteoclastogenesis, and the activation of RhoA by RANKL was also significantly suppressed by Gα12 deficiency. We further found that the RANKL induction of NFATc1 was not dependent on RhoA signalling, while osteoclast precursor migration and bone resorption required RhoA in the Gα12-mediated regulation of osteoclasts. Therefore, Gα12 plays a role in differentiation through NFATc1 and in cell migration and resorption activity through RhoA during osteoclastogenesis.

摘要

G 蛋白α亚基 G12 家族被证实参与了多种生理过程的调节。然而,Gα12 在骨生理学中的作用尚未得到充分描述。在这里,通过 micro-CT 分析,我们发现 Gα12 敲除小鼠表现出成骨过度的表型。组织学检查显示,与野生型小鼠相比,Gα12 敲除小鼠股骨组织中的破骨细胞数量较少。此外,用核因子κB 受体激活剂配体(RANKL)诱导前体细胞的体外破骨细胞分化显示,Gα12 缺失减少了生成的破骨细胞数量和骨吸收活性。核因子活化 T 细胞 c1(NFATc1)的诱导,破骨细胞生成的关键转录因子,以及 RANKL 对 RhoA 的激活也被 Gα12 缺失显著抑制。我们进一步发现,RANKL 诱导的 NFATc1 不依赖于 RhoA 信号通路,而破骨细胞前体的迁移和骨吸收在 Gα12 介导的破骨细胞调节中需要 RhoA。因此,Gα12 在破骨细胞分化中通过 NFATc1 发挥作用,在细胞迁移和骨吸收活性中通过 RhoA 发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/ae3797333507/JCMM-22-849-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/f7c3f0d5acaf/JCMM-22-849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/05a06696b105/JCMM-22-849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/e9acf6805dfa/JCMM-22-849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/64b2b2470bdf/JCMM-22-849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/ae3797333507/JCMM-22-849-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/f7c3f0d5acaf/JCMM-22-849-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/05a06696b105/JCMM-22-849-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/e9acf6805dfa/JCMM-22-849-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/64b2b2470bdf/JCMM-22-849-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8b81/5783869/ae3797333507/JCMM-22-849-g005.jpg

相似文献

1
Gα12 regulates osteoclastogenesis by modulating NFATc1 expression.Gα12 通过调节 NFATc1 的表达来调节破骨细胞的生成。
J Cell Mol Med. 2018 Feb;22(2):849-860. doi: 10.1111/jcmm.13370. Epub 2017 Oct 27.
2
Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.曲匹地尔,一种血小板衍生生长因子拮抗剂,通过下调 NFATc1 抑制破骨细胞生成,并抑制小鼠的骨丢失。
Biochem Pharmacol. 2013 Sep 15;86(6):782-90. doi: 10.1016/j.bcp.2013.07.015. Epub 2013 Aug 6.
3
Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.咖啡酸 3,4-二羟基苯乙基酯通过抑制丝裂原活化蛋白激酶/激活蛋白 1 和 Ca2+-活化 T 细胞胞浆 1 信号通路抑制核因子 κB 配体诱导的破骨细胞生成,预防卵巢切除诱导的骨丢失。
J Bone Miner Res. 2012 Jun;27(6):1298-1308. doi: 10.1002/jbmr.1576.
4
Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.新型NF-κB抑制剂(-)-DHMEQ通过下调NFATc1抑制RANKL诱导的破骨细胞生成。
J Bone Miner Res. 2005 Apr;20(4):653-62. doi: 10.1359/JBMR.041213. Epub 2004 Dec 6.
5
Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.槐花提取物通过抑制小鼠骨髓细胞中的NF-κB/NFATc1信号通路来抑制RANKL诱导的破骨细胞分化。
BMC Complement Altern Med. 2017 Mar 23;17(1):164. doi: 10.1186/s12906-016-1550-x.
6
Adseverin mediates RANKL-induced osteoclastogenesis by regulating NFATc1.促粘着斑蛋白通过调节活化T细胞核因子c1介导核因子κB受体活化因子配体诱导的破骨细胞生成。
Exp Mol Med. 2015 Dec 18;47(12):e199. doi: 10.1038/emm.2015.94.
7
MicroRNA-124 regulates osteoclast differentiation.微小 RNA-124 调控破骨细胞分化。
Bone. 2013 Oct;56(2):383-9. doi: 10.1016/j.bone.2013.07.007. Epub 2013 Jul 15.
8
BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.骨唾液蛋白(BSP)和核因子κB受体活化因子配体(RANKL)协同诱导破骨细胞生成和骨吸收。
J Bone Miner Res. 2005 Sep;20(9):1669-79. doi: 10.1359/JBMR.050511. Epub 2005 May 16.
9
CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.CTRP3在体外通过AMPK-c-Fos-NFATc1信号传导充当破骨细胞生成的负调节因子,并在体内抑制RANKL诱导的颅骨骨破坏。
Bone. 2015 Oct;79:242-51. doi: 10.1016/j.bone.2015.06.011. Epub 2015 Jun 21.
10
Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice.醋酸齐墩果酸通过下调 PLCγ2-Ca(2+)-NFATc1 信号通路抑制破骨细胞分化,并抑制小鼠的骨丢失。
Bone. 2014 Mar;60:104-11. doi: 10.1016/j.bone.2013.12.013. Epub 2013 Dec 17.

引用本文的文献

1
Involvement of icaritin in the regulation of osteocyte exosomal microRNAs.淫羊藿素参与骨细胞外泌体微小RNA的调控。
J Orthop Surg Res. 2025 Feb 14;20(1):164. doi: 10.1186/s13018-025-05583-9.
2
GPCR-Gα13 Involvement in Mitochondrial Function, Oxidative Stress, and Prostate Cancer.G 蛋白偶联受体-Gα13 参与线粒体功能、氧化应激和前列腺癌。
Int J Mol Sci. 2024 Jun 28;25(13):7162. doi: 10.3390/ijms25137162.
3
Gα modulates the energy metabolism of osteoclasts.Gα 调节破骨细胞的能量代谢。

本文引用的文献

1
ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.ATF3通过与c-Fos和NFATc1蛋白结合来调节破骨细胞分化和活性中的钙信号传导。
Bone. 2017 Feb;95:33-40. doi: 10.1016/j.bone.2016.11.005. Epub 2016 Nov 6.
2
Regulation of NFATc1 in Osteoclast Differentiation.破骨细胞分化过程中NFATc1的调控
J Bone Metab. 2014 Nov;21(4):233-41. doi: 10.11005/jbm.2014.21.4.233. Epub 2014 Nov 30.
3
FoxO proteins restrain osteoclastogenesis and bone resorption by attenuating H2O2 accumulation.
Front Cell Infect Microbiol. 2023 Jan 9;12:1016299. doi: 10.3389/fcimb.2022.1016299. eCollection 2022.
4
Exploring the Expression of Pro-Inflammatory and Hypoxia-Related MicroRNA-20a, MicroRNA-30e, and MicroRNA-93 in Periodontitis and Gingival Mesenchymal Stem Cells under Hypoxia.探讨促炎和缺氧相关 microRNA-20a、microRNA-30e 和 microRNA-93 在牙周炎和缺氧状态下牙龈间充质干细胞中的表达。
Int J Mol Sci. 2022 Sep 7;23(18):10310. doi: 10.3390/ijms231810310.
5
Gα and Gα: Versatility in Physiology and Pathology.Gα与Gα:生理与病理中的多功能性
Front Cell Dev Biol. 2022 Feb 14;10:809425. doi: 10.3389/fcell.2022.809425. eCollection 2022.
6
Effects of the Lysine Methyltransferase Inhibitor AZ505 on Bone Metabolism.赖氨酸甲基转移酶抑制剂AZ505对骨代谢的影响。
J Bone Metab. 2021 Nov;28(4):297-305. doi: 10.11005/jbm.2021.28.4.297. Epub 2021 Nov 30.
7
Extracellular vesicles derived from the periodontal pathogen Filifactor alocis induce systemic bone loss through Toll-like receptor 2.来源于牙周致病菌福赛拟杆菌的细胞外囊泡通过 Toll 样受体 2 诱导系统性骨丢失。
J Extracell Vesicles. 2021 Oct;10(12):e12157. doi: 10.1002/jev2.12157.
8
Signaling mechanisms and physiological functions of G-protein Gα in blood vessel formation, bone homeostasis, and cancer.G 蛋白 Gα 在血管生成、骨稳态和癌症中的信号机制和生理功能。
Protein Sci. 2019 Feb;28(2):305-312. doi: 10.1002/pro.3531. Epub 2018 Nov 15.
FoxO 蛋白通过减弱 H2O2 积累来抑制破骨细胞生成和骨吸收。
Nat Commun. 2014 Apr 30;5:3773. doi: 10.1038/ncomms4773.
4
The paired-box homeodomain transcription factor Pax6 binds to the upstream region of the TRAP gene promoter and suppresses receptor activator of NF-κB ligand (RANKL)-induced osteoclast differentiation.配对盒同源结构域转录因子 Pax6 与 TRAP 基因启动子的上游区域结合,抑制核因子-κB 受体激活剂配体(RANKL)诱导的破骨细胞分化。
J Biol Chem. 2013 Oct 25;288(43):31299-312. doi: 10.1074/jbc.M113.461848. Epub 2013 Aug 29.
5
G12/13-dependent signaling of G-protein-coupled receptors: disease context and impact on drug discovery.G 蛋白偶联受体的 G12/13 依赖性信号转导:疾病背景及其对药物发现的影响。
Expert Opin Drug Discov. 2007 Dec;2(12):1591-604. doi: 10.1517/17460441.2.12.1591.
6
Akt induces osteoclast differentiation through regulating the GSK3β/NFATc1 signaling cascade.Akt 通过调节 GSK3β/NFATc1 信号级联诱导破骨细胞分化。
J Immunol. 2012 Jan 1;188(1):163-9. doi: 10.4049/jimmunol.1101254. Epub 2011 Nov 30.
7
Osteoclastogenic activity and RANKL expression are inhibited in osteoblastic cells expressing constitutively active Gα(12) or constitutively active RhoA.破骨细胞生成活性和 RANKL 表达在表达组成性激活 Gα(12)或组成性激活 RhoA 的成骨细胞中受到抑制。
J Cell Biochem. 2010 Dec 15;111(6):1531-6. doi: 10.1002/jcb.22883.
8
G(12)/G(13)-mediated signalling in mammalian physiology and disease.G(12)/G(13)介导的信号传导在哺乳动物生理学和疾病中的作用
Trends Pharmacol Sci. 2008 Nov;29(11):582-9. doi: 10.1016/j.tips.2008.08.002. Epub 2008 Sep 22.
9
Brain-type creatine kinase has a crucial role in osteoclast-mediated bone resorption.脑型肌酸激酶在破骨细胞介导的骨吸收中起关键作用。
Nat Med. 2008 Sep;14(9):966-72. doi: 10.1038/nm.1860.
10
G12/13 and Gq mediate S1P2-induced inhibition of Rac and migration in vascular smooth muscle in a manner dependent on Rho but not Rho kinase.G12/13和Gq以一种依赖于Rho而非Rho激酶的方式介导S1P2诱导的血管平滑肌中Rac抑制和迁移。
Cardiovasc Res. 2008 Sep 1;79(4):689-97. doi: 10.1093/cvr/cvn118. Epub 2008 May 14.